Polyclonal T-cells express CD1a in Langerhans cell histiocytosis (LCH) lesions

Jennifer A West1, Sharon L Olsen1, Jenée M Mitchell1

  • 1Fiona Elsey Cancer Research Institute, Ballarat, Victoria, Australia; School of Health Sciences, Federation University, Mt Helen, Victoria, Australia.

Plos One
|October 25, 2014
PubMed

Insights

Researchers discovered CD1a-expressing T-cells in Langerhans cell histiocytosis (LCH) lesions, challenging the belief that only Langerhans cells (LCs) express CD1a. This finding may impact understanding of LCH pathogenesis.

Area of Science:

  • Immunology
  • Oncology
  • Cell Biology

Background:

  • Langerhans cell histiocytosis (LCH) is a complex disorder with inflammatory and neoplastic features.
  • CD1a expression is a hallmark of LCH, traditionally associated solely with pathogenic Langerhans cells (LCs).

Purpose of the Study:

  • To investigate the cellular expression of CD1a within LCH lesions.
  • To determine if CD1a expression is restricted to LCs in LCH.

Main Methods:

  • Eight-colour flow cytometry was utilized to analyze cell populations in LCH lesions.

Main Results:

  • A previously unreported population of CD1a-positive and CD3-positive T-cells was identified in LCH lesions.
  • CD1a expression was detected on various T-cell subsets across all examined LCH lesions.
  • This indicates CD1a expression is not exclusive to pathogenic LCs in LCH.

Conclusions:

  • CD1a expression in LCH lesions is broader than previously understood, involving T-cells.
  • The presence of CD1a-expressing T-cells necessitates further research into their role in LCH pathogenesis.